Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway.

Kim, Daejin; Ko, Hyun-Suk; Park, Ga Bin; Hur, Dae Young; Kim, Yeong Seok; Yang, Jae Wook

Kim, Daejin; Ko, Hyun-Suk; Park, Ga Bin; Hur, Dae Young; Kim, Yeong Seok; Yang, Jae Wook.

Afiliação

Kim D; Department of Anatomy, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan 614-735, Republic of Korea.
Ko HS; Ocular Neovascular Disease Research Center, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan 614-735, Republic of Korea.
Park GB; Department of Anatomy, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan 614-735, Republic of Korea.
Hur DY; Department of Anatomy, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan 614-735, Republic of Korea.
Kim YS; Ocular Neovascular Disease Research Center, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan 614-735, Republic of Korea.
Yang JW; Department of Anatomy, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan 614-735, Republic of Korea.

Exp Ther Med ; 13(4): 1415-1425, 2017 Apr.

Article em En | MEDLINE | ID: mdl-28413487

Palavras-chave

disintegrin and metalloprotease protein; epithelial-mesenchymal transition; retina pigment epithelial cells; vandetanib; vascular endothelial growth factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article